Drugs / PT-MSCs Exosomes
PT-MSCs Exosomes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07409259 | Jan 2026 → Aug 2027 expected | liver disorder | Third Affiliated Hospital, Sun Yat-Sen University | Active not recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PT-MSCs Exosomes | “participants will receive PT-MSCs Exosomes” NCT07409259 ↗ |
| Known as | PT-MSCs Exosome Injection | “PT-MSCs Exosome Injection (Code: PT-MSCs-EVS-2023-1)” NCT07409259 ↗ |
| Known as | PT-MSCs-EVS-2023-1 | “PT-MSCs Exosome Injection (Code: PT-MSCs-EVS-2023-1)” NCT07409259 ↗ |
| Modality | Other / unclassified | “Biological: exosome injection” NCT07409259 ↗ |
| Route | Intravenous | “administered via intravenous infusion” NCT07409259 ↗ |